Evidence Synthesis And Classification Branch (ESC) - IARC

Trang chủ » Hu Dp Et Al. (indian J Cancer 2021) » Evidence Synthesis And Classification Branch (ESC) - IARC

Có thể bạn quan tâm

Publications

All recent publications: 2026-2022

View Key Publications
  1. Craciun OM, Garcia-Ovejero E, Campbell F, Montes-Mota M, Holdenrieder S, Trulson I, et al. (2026). Development of a decision tree diagram for classifying study designs in tumour pathology research: a multidisciplinary approach. J Pathol Clin Res. 12(1): e70056. https://doi.org/10.1002/2056-4538.70056 PMID: 41317315
  2. Goldman-Levy G, Barnhill R, Bastian BC, Kempf W, Elder D, Gerami P, et al. (2026). WHO classification of skin tumours: key updates in the fifth edition. Histopathology. 88(3): 555-568. https://doi.org/10.1111/his.15562 PMID: 41263762
  3. Rumgay H, Colombet M, Ramos da Cunha A, Filho AM, Warnakulasuriya S, Conway DI, et al. (2026). Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022. CA Cancer J Clin. 76(1). https://doi.org/10.3322/caac.70048 PMID: 41335400
  4. Barahona-Lopez C, Plans-Beriso E, Diez-Echave P, Hernandez O, de Larrea NF, Craciun O, et al. (2025). Personalized prevention of neurodegenerative diseases: scoping review and evidence gap map. Alzheimers Dement. 21(12): e70980. https://doi.org/10.1002/alz.70980 PMID: 41366852
  5. Boycott C, Beetch M, Lubecka-Gajewska K, Ramsey BS, Torregrosa-Allen S, Elzey BD, et al. (2025). AMPK-Dependent Epigenetic Regulation of Metabolism Mediates the Anti-Cancer Action of Pterostilbene in Hepatocellular Carcinoma. Mol Nutr Food Res. 69(23): e70217. https://doi.org/10.1002/mnfr.70217 PMID: 40888265
  6. Capucetti A, Falivene J, Pizzichetti C, Latino I, Mazzucchelli L, Schacht V, et al. (2025). Tattoo ink induces inflammation in the draining lymph node and alters the immune response to vaccination. Proc Natl Acad Sci U S A. 122(48): e2510392122. https://doi.org/10.1073/pnas.2510392122 PMID: 41289395
  7. Cogliano VJ, Corsini E, Fournier A, Nelson HH, Sergi CM, Antunes AMM, et al. (2025). Carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus. Lancet Oncol. 26(1): 15-16. https://doi.org/10.1016/S1470-2045(24)00685-5 PMID: 39622256
  8. de Conti A, Madia F, Schubauer-Berigan MK, Benbrahim-Tallaa L (2025). Carcinogenicity of some metals evaluated by the IARC Monographs: A synopsis of the evaluations of arsenic, cadmium, cobalt, and antimony. Toxicol Appl Pharmacol. 504: 117506. https://doi.org/10.1016/j.taap.2025.117506 PMID: 40780533
  9. DeBono NL, Amar V, Hardy H, Schubauer-Berigan MK, Ruths D, King NB (2025). A large language model-based tool for identifying relationships to industry in research on the carcinogenicity of benzene, cobalt, and aspartame. Environ Health. 24(1): 64. https://doi.org/10.1186/s12940-025-01223-1 PMID: 40993649
  10. DeMarini DM, Gwinn W, Watkins E, Reisfeld B, Chiu WA, Zeise L, et al. (2025). IARC Workshop on the Key Characteristics of Carcinogens: Assessment of End Points for Evaluating Mechanistic Evidence of Carcinogenic Hazards. Environ Health Perspect. 133(2): 25001. https://doi.org/10.1289/EHP15389 PMID: 39899356
  11. Diaz-Gay M, Dos Santos W, Moody S, Kazachkova M, Abbasi A, Steele CD, et al. (2025). Geographic and age variations in mutational processes in colorectal cancer. Nature. 643(8070): 230-240. https://doi.org/10.1038/s41586-025-09025-8 PMID: 40267983
  12. Gapstur SM, Mariosa D, Neamtiu L, Nethan ST, Rehm J, Huckle T, et al. (2025). The IARC Perspective on the Effects of Policies on Reducing Alcohol Consumption. N Engl J Med. 392(17): 1752-1759. https://doi.org/10.1056/NEJMsr2413289 PMID: 40305721
  13. Giesen C, Goldman-Levy G, Cree IA, Cierco Jimenez R, Machado A, Lokuhetty D (2025). WHO Classification of Tumours: moving towards the sixth edition. Histopathology. 86(6): 839-844. https://doi.org/10.1111/his.15325 PMID: 39293942
  14. Hassell LA, Forsythe ML, Bhalodia A, Lan T, Rashid T, Powers A, et al. (2025). Toward Optimizing the Impact of Digital Pathology and Augmented Intelligence on Issues of Diagnosis, Grading, Staging, and Classification. Mod Pathol. 38(7): 100765. https://doi.org/10.1016/j.modpat.2025.100765 PMID: 40204094
  15. Hodge JC, Netto GJ, Rekhi B, Cooper WA, Eden M, Field AS, et al. (2025). WHO Classification of Tumours: evolution of a global resource in the molecular era. Lancet Oncol. 26(4): 410-413. https://doi.org/10.1016/S1470-2045(24)00709-5 PMID: 40179904
  16. Lauby-Secretan B (2025). Response to the current perspective: Evaluation of screening mammography effectiveness: The IARC recommendations of 2015 need revision. Eur J Cancer. 226: 115658. https://doi.org/10.1016/j.ejca.2025.115658 PMID: 40729841
  17. Mariosa D, Ponzano M, Grotta A, Lagerros YT, Hantikainen E, Adami HO, et al. (2025). Dietary non-enzymatic antioxidant capacity and risk of breast cancer: the Swedish National March Cohort. BMC Cancer. 25(1): 1310. https://doi.org/10.1186/s12885-025-14658-z PMID: 40797303
  18. Matta K, Viallon V, Chatziioannou AC, Robinot N, Wedekind R, Dahm CC, et al. (2025). Can serum metabolic signatures inform on the relationship between healthy lifestyle and colon cancer risk? Cancer Metab. 13(1): 30. https://doi.org/10.1186/s40170-025-00388-0 PMID: 40524238
  19. Mehrotra R, Lauby-Secretan B (2025). Smokeless Tobacco Is a Major Risk Factor for Oral Cancer in South and Southeast Asia. Oral Dis. 31(5): 1473-1478. https://doi.org/10.1111/odi.15241 PMID: 39928051
  20. Richardson DB, Laurier D, Haylock R, Kelly-Reif K, Bertke S, Daniels RD, et al. (2025). Worker studies and their interpretation. J Radiol Prot. 45(3). https://doi.org/10.1088/1361-6498/ade68e PMID: 40654101
  21. Richardson DB, Laurier D, Leuraud K, Gillies M, Haylock R, Kelly-Reif K, et al. (2025). Site-specific cancer mortality after low-level exposure to ionizing radiation: findings from an update of the International Nuclear Workers Study (INWORKS). Am J Epidemiol. 194(5): 1285-1294. https://doi.org/10.1093/aje/kwae256 PMID: 39108174
  22. Schmidt L, Cree I, Campbell F, group WEM (2025). Digital Tools to Support the Systematic Review Process: An Introduction. J Eval Clin Pract. 31(3): e70100. https://doi.org/10.1111/jep.70100 PMID: 40290054
  23. Schubauer-Berigan MK, Bertke SJ, Kelly-Reif K, Daniels RD (2025). Updated cancer mortality among uranium miners on the Colorado Plateau: interactions of radon exposure with smoking and temporal factors. Occup Environ Med. https://doi.org/10.1136/oemed-2025-110297 PMID: 40579177
  24. Steenland K, Straif K, Schubauer-Berigan MK, Demers PA, Forastiere F, Stenzel T, et al. (2025). Letter: Robins-E risk of bias tool. Environ Int. 199: 109463. https://doi.org/10.1016/j.envint.2025.109463 PMID: 40307162
  25. Torrens L, Moody S, de Carvalho AC, Kazachkova M, Abedi-Ardekani B, Cheema S, et al. (2025). The complexity of tobacco smoke-induced mutagenesis in head and neck cancer. Nat Genet. 57(4): 884-896. https://doi.org/10.1038/s41588-025-02134-0 PMID: 40164736
  26. Turner MC, Basagana X, Albin M, Broberg K, Burdorf A, van Daalen KR, et al. (2025). Occupational health in the era of climate change and the green transition: a call for research. Lancet Reg Health Eur. 54: 101353. https://doi.org/10.1016/j.lanepe.2025.101353 PMID: 40613104
  27. Villiers CB, Plans-Beriso E, Erady C, Blackburn L, Wilson H, Turner H, et al. (2025). Biomarkers for Personalised Primary or Secondary Prevention in Cardiovascular Diseases: A Rapid Scoping Review. Int J Mol Sci. 26(19): 9346. https://doi.org/10.3390/ijms26199346 PMID: 41096615
  28. Centeno BA, Saieg M, Siddiqui MT, Perez-Machado M, Layfield LJ, Weynand B, et al. (2024). The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Overview and Summary. Cancer Cytopathol. 132(7): 396-418. https://doi.org/10.1002/cncy.22806 PMID: 38709670
  29. Colling R, Indave I, Del Aguila J, Jimenez RC, Campbell F, Chechlinska M, et al. (2024). A New Hierarchy of Research Evidence for Tumor Pathology: A Delphi Study to Define Levels of Evidence in Tumor Pathology. Mod Pathol. 37(1): 100357. https://doi.org/10.1016/j.modpat.2023.100357 PMID: 37866639
  30. Colling R, Indave I, Del Aguilla J, Cierco Jimenez R, Campbell F, Chechlinska M, et al. (2024). Moving Forward on Tumor Pathology Research Reporting: A Guide for Pathologists From the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group. Mod Pathol. 37(7): 100515. https://doi.org/10.1016/j.modpat.2024.100515 PMID: 38763419
  31. Daniels RD, Bertke SJ, Kelly-Reif K, Richardson DB, Haylock R, Laurier D, et al. (2024). Updated findings on temporal variation in radiation-effects on cancer mortality in an international cohort of nuclear workers (INWORKS). Eur J Epidemiol. 39(11): 1277-1286. https://doi.org/10.1007/s10654-024-01178-6 PMID: 39576361
  32. Giesen C, Del Aguila Mejia J, Armon S, Cierco Jimenez R, Myles N, Goldman-Levy G, et al. (2024). Exploratory evidence maps for the WHO Classification of Tumours 5th edition for lung and thymus tumors. Virchows Arch. 485(5): 869-878. https://doi.org/10.1007/s00428-024-03886-6 PMID: 39448408
  33. Harewood R, Rothwell JA, Besevic J, Viallon V, Achaintre D, Gicquiau A, et al. (2024). Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC). EBioMedicine. 101: 105024. https://doi.org/10.1016/j.ebiom.2024.105024 PMID: 38412638
  34. Kreuzer M, Sommer M, Deffner V, Bertke S, Demers PA, Kelly-Reif K, et al. (2024). Lifetime excess absolute risk for lung cancer due to exposure to radon: results of the pooled uranium miners cohort study PUMA. Radiat Environ Biophys. 63(1): 7-16. https://doi.org/10.1007/s00411-023-01049-w PMID: 38172372
  35. Leuraud K, Laurier D, Gillies M, Haylock R, Kelly-Reif K, Bertke S, et al. (2024). Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study. Lancet Haematol. 11(10): e761-e769. https://doi.org/10.1016/S2352-3026(24)00240-0 PMID: 39222647
  36. Middleton DRS, Wedekind R, Hall AL, Suonio E, DeBono N, Vermeulen R, et al. (2024). Critical reviews of exposure assessment in carcinogenic hazard identification: the IARC Monographs experience. Occup Environ Med. 81(7): 366-372. https://doi.org/10.1136/oemed-2023-109277 PMID: 39033030
  37. Perdomo S, Abedi-Ardekani B, de Carvalho AC, Ferreiro-Iglesias A, Gaborieau V, Cattiaux T, et al. (2024). The Mutographs biorepository: A unique genomic resource to study cancer around the world. Cell Genom. 4(3): 100500. https://doi.org/10.1016/j.xgen.2024.100500 PMID: 38325367
  38. Rumgay H, Nethan ST, Shah R, Vignat J, Ayo-Yusuf O, Chaturvedi P, et al. (2024). Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis. Lancet Oncol. 25(11): 1413-1423. https://doi.org/10.1016/S1470-2045(24)00458-3 PMID: 39393386
  39. Senkin S, Moody S, Diaz-Gay M, Abedi-Ardekani B, Cattiaux T, Ferreiro-Iglesias A, et al. (2024). Geographic variation of mutagenic exposures in kidney cancer genomes. Nature. 629(8013): 910-918. https://doi.org/10.1038/s41586-024-07368-2 PMID: 38693263
  40. Shafique A, Gonzalez R, Pantanowitz L, Tan PH, Machado A, Cree IA, et al. (2024). A Preliminary Investigation into Search and Matching for Tumor Discrimination in World Health Organization Breast Taxonomy Using Deep Networks. Mod Pathol. 37(2): 100381. https://doi.org/10.1016/j.modpat.2023.100381 PMID: 37939901
  41. Sohi I, Rehm J, Saab M, Virmani L, Franklin A, Sanchez G, et al. (2024). Alcoholic beverage consumption and female breast cancer risk: A systematic review and meta-analysis of prospective cohort studies. Alcohol Clin Exp Res (Hoboken). 48(12): 2222-2241. https://doi.org/10.1111/acer.15493 PMID: 39581746
  42. Stayner LT, Carreon-Valencia T, Demers PA, Fritz JM, Sim MR, Stewart P, et al. (2024). Carcinogenicity of talc and acrylonitrile. Lancet Oncol. 25(8): 962-963. https://doi.org/10.1016/S1470-2045(24)00384-X PMID: 38976996
  43. Terry MB, English DR, Freudenheim JL, Lauby-Secretan B, Gapstur SM (2024). Alcohol cessation and breast cancer risk stratified by hormone receptor status. Breast Cancer Res. 26(1): 179. https://doi.org/10.1186/s13058-024-01937-z PMID: 39639353
  44. Tran TV, Schonfeld SJ, Pasqual E, Haymart MR, Morton LM, Kitahara CM (2024). All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States. Thyroid. 34(2): 215-224. https://doi.org/10.1089/thy.2023.0449 PMID: 38149602
  45. Turner MC, Straif K, Kogevinas M, Schubauer-Berigan MK (2024). Five decades of occupational cancer epidemiology. Scand J Work Environ Health. 50(7): 489-502. https://doi.org/10.5271/sjweh.4190 PMID: 39311490
  46. Wong CJW, Md Nasir ND, Koh VCY, Campbell F, Fox S, Lakhani SR, et al. (2024). Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breast. Histopathology. 85(3): 510-520. https://doi.org/10.1111/his.15279 PMID: 39030792
  47. Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, et al. (2024). Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. Lancet Oncol. 25(1): 16-17. https://doi.org/10.1016/S1470-2045(23)00622-8 PMID: 38043561
  48. Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, de Oliveira Araujo IB, Berti E, et al. (2023). Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720-1748. Leukemia. 37(9): 1944-1951. https://doi.org/10.1038/s41375-023-01962-5 PMID: 37468552
  49. Bresalier RS, Senore C, Young GP, Allison J, Benamouzig R, Benton S, et al. (2023). An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles. Gut. 72(10): 1904-1918. https://doi.org/10.1136/gutjnl-2023-329701 PMID: 37463757
  50. Canberk S, Field A, Bubendorf L, Chandra A, Cree IA, Engels M, et al. (2023). A brief review of the WHO reporting system for lung cytopathology. Journal of the American Society of Cytopathology. 12(4): 251-257. https://doi.org/10.1016/j.jasc.2023.04.002 PMID: 37156705
  51. Cattley RC, Kromhout H, Sun M, Tokar EJ, Abdallah MA, Bauer AK, et al. (2023). Carcinogenicity of anthracene, 2-bromopropane, butyl methacrylate, and dimethyl hydrogen phosphite. Lancet Oncol. 24(5): 431-432. https://doi.org/10.1016/S1470-2045(23)00141-9 PMID: 36966774
  52. Cree IA (2023). Editorial: The new WHO cytopathology reporting systems-extending the WHO classification of tumors. J Am Soc Cytopathol. 12(4): 239-242. https://doi.org/10.1016/j.jasc.2023.04.004 PMID: 37244847
  53. Cree IA, Khoury JD (2023). WHO or International Consensus Classification: Is the Difference Worth It? J Clin Oncol. 41(31): 4937-4938. https://doi.org/10.1200/jco.23.01172 PMID: 37467455
  54. DeBono NL, Daniels RD, Beane Freeman LE, Graber JM, Hansen J, Teras LR, et al. (2023). Firefighting and Cancer: A Meta-analysis of Cohort Studies in the Context of Cancer Hazard Identification. Saf Health Work. 14(2): 141-152. https://doi.org/10.1016/j.shaw.2023.02.003 PMID: 37389311
  55. Gapstur SM, Bouvard V, Nethan ST, Freudenheim JL, Abnet CC, English DR, et al. (2023). The IARC Perspective on Alcohol Reduction or Cessation and Cancer Risk. N Engl J Med. 389(26): 2486-2494. https://doi.org/10.1056/NEJMsr2306723 PMID: 38157507
  56. Gregorio C, Thakur S, Camara Rivero R, Marcia Dos Santos Machado S, Cuenin C, Carreira C, et al. (2023). Telomere length assessment and molecular characterization of TERT gene promoter in periampullary carcinomas. Gene. 873: 147460. https://doi.org/10.1016/j.gene.2023.147460 PMID: 37150235
  57. Haycock PC, Borges MC, Burrows K, Lemaitre RN, Burgess S, Khankari NK, et al. (2023). The association between genetically elevated polyunsaturated fatty acids and risk of cancer. EBioMedicine. 91: 104510. https://doi.org/10.1016/j.ebiom.2023.104510 PMID: 37086649
  58. Kelly-Reif K, Bertke S, Daniels RD, Richardson DB, Schubauer-Berigan MKD (2023). Authors’ response: Solid cancer mortality among US radiation workers. Int J Epidemiol. 52(6): 1994-1995. https://doi.org/10.1093/ije/dyad132 PMID: 37741933
  59. Kelly-Reif K, Bertke SJ, Daniels RD, Richardson DB, Schubauer-Berigan MK (2023). Ionizing radiation and solid cancer mortality among US nuclear facility workers. Int J Epidemiol. 52(4): 1015-1024. https://doi.org/10.1093/ije/dyad075 PMID: 37253388
  60. Kelly-Reif K, Bertke SJ, Rage E, Demers PA, Fenske N, Deffner V, et al. (2023). Radon and lung cancer in the pooled uranium miners analysis (PUMA): highly exposed early miners and all miners. Occup Environ Med. 80(7): 385-391. https://doi.org/10.1136/oemed-2022-108532 PMID: 37164624
  61. Lennerz JK, Salgado R, Kim GE, Sirintrapun SJ, Thierauf JC, Singh A, et al. (2023). Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML. Clin Chem Lab Med. 61(4): 544-557. https://doi.org/10.1515/cclm-2022-1151 PMID: 36696602
  62. M Filho A, Turner MC, Warnakulasuriya S, Richardson DB, Hosseini B, Kamangar F, et al. (2023). The carcinogenicity of opium consumption: a systematic review and meta-analysis. Eur J Epidemiol. 38(4): 373-389. https://doi.org/10.1007/s10654-023-00969-7 PMID: 36773182
  63. Malir F, Pickova D, Toman J, Grosse Y, Ostry VM (2023). Hazard characterisation for significant mycotoxins in food. Mycotoxin Res. 39(2): 81-93. https://doi.org/10.1007/s12550-023-00478-2 PMID: 36930431
  64. Mandrik O, Roitberg F, Lauby-Secretan B, Parak U, Ramadas K, Varenne B, et al. (2023). Perspective on oral cancer screening: Time for implementation research and beyond. J Cancer Policy. 35: 100381. https://doi.org/10.1016/j.jcpo.2022.100381 PMID: 36599217
  65. Md Nasir ND, Koh VCY, Cree IA, Ruiz BII, Del Aguila J, Armon S, et al. (2023). Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast. Histopathology. 82(5): 704-712. https://doi.org/10.1111/his.14856 PMID: 36579383
  66. Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, et al. (2023). WHO 2022 classification of penile and scrotal cancers: updates and evolution. Histopathology. 82(4): 508-520. https://doi.org/10.1111/his.14824 PMID: 36221864
  67. Milman T, Grossniklaus HE, Goldman-Levy G, Kivela TT, Coupland SE, White VA, et al. (2023). The 5th Edition of the World Health Organization Classification of Tumours of the Eye and Orbit. Ocul Oncol Pathol. 9(3-4): 71-95. https://doi.org/10.1159/000530730 PMID: 37900189
  68. Netto GJ, Amin MB, Comperat EM, Gill AJ, Hartmann A, Moch H, et al. (2023). Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. Eur Urol. 83(4): 301-303. https://doi.org/10.1016/j.eururo.2022.09.015 PMID: 36202687
  69. Pedroso CM, Normando AGC, Siracusa CS, Lauby-Secretan B, Nethan ST, Tomasi RA, et al. (2023). Pan-American prevalence of smokeless tobacco use and association with oral potentially malignant disorders and head and neck cancer: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 136(3): 322-332. https://doi.org/10.1016/j.oooo.2023.02.019 PMID: 37076380
  70. Pega F, Momen NC, Streicher KN, Leon-Roux M, Neupane S, Schubauer-Berigan MK, et al. (2023). Global, regional and national burdens of non-melanoma skin cancer attributable to occupational exposure to solar ultraviolet radiation for 183 countries, 2000–2019: A systematic analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Environ Int. 181: 108226. https://doi.org/10.1016/j.envint.2023.108226 PMID: 37945424
  71. Pitman MB, Centeno BA, Reid MD, Saeig M, Siddiqui MT, Layfield LJ, et al. (2023). A brief review of the WHO reporting system for pancreaticobiliary cytopathology. J Am Soc Cytopathol. 12(4): 243-250. https://doi.org/10.1016/j.jasc.2023.03.002 PMID: 37003924
  72. Pitman MB, Centeno BA, Reid MD, Siddiqui MT, Layfield LJ, Perez-Machado M, et al. (2023). The World Health Organization Reporting System for Pancreaticobiliary Cytopathology. Acta Cytol. 67(3): 304-320. https://doi.org/10.1159/000527912 PMID: 36516741
  73. Riboli E, Beland FA, Lachenmeier DW, Marques MM, Phillips DH, Schernhammer E, et al. (2023). Carcinogenicity of aspartame, methyleugenol, and isoeugenol. Lancet Oncol. 24(8): 848-850. https://doi.org/10.1016/S1470-2045(23)00341-8 PMID: 37454664
  74. Richardson DB, Leuraud K, Laurier D, Gillies M, Haylock R, Kelly-Reif K, et al. (2023). Cancer mortality after low dose exposure to ionising radiation in workers in France, the United Kingdom, and the United States (INWORKS): cohort study. BMJ. 382: e074520. https://doi.org/10.1136/bmj-2022-074520 PMID: 37586731
  75. Rubin MA, Amin MB, Comperat E, Gill A, Hartman A, Menon S, et al. (2023). Reply to Yongbao Wei, Haijian Huang, and Liefu Ye’s Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469-82. Eur Urol. 83(1): e16-e17. https://doi.org/10.1016/j.eururo.2022.09.021 PMID: 36202688
  76. Schmitt FC, Bubendorf L, Canberk S, Chandra A, Cree IA, Engels M, et al. (2023). The World Health Organization Reporting System for Lung Cytopathology. Acta Cytol. 67(1): 80-91. https://doi.org/10.1159/000527580 PMID: 36509066
  77. Schorb S, Gleiss K, Wedekind R, Suonio E, Kull AK, Kuntz M, et al. (2023). Assessment of Aspartame (E951) Occurrence in Selected Foods and Beverages on the German Market 2000-2022. Foods. 12(11). https://doi.org/10.3390/foods12112156 PMID: 37297402
  78. Schubauer-Berigan MK (2023). Invited Perspective: Good Measure-Assessing the Impact of Cancer Hazard Identification on Policies for Cancer Prevention. Environ Health Perspect. 131(12): 121302. https://doi.org/10.1289/EHP14099 PMID: 38088578
  79. Schubauer-Berigan MK, Richardson DB, Fox MP, Fritschi L, Guseva Canu I, Pearce N, et al. (2023). IARC-NCI workshop on an epidemiological toolkit to assess biases in human cancer studies for hazard identification: beyond the algorithm. Occup Environ Med. 80(3): 119-120. https://doi.org/10.1136/oemed-2022-108724 PMID: 36717257
  80. Siebert R, Schuh A, Ott G, Cree IA, Du MQ, Ferry J, et al. (2023). Response to the Comments from the Groupe Francophone de Cytogenetique Hematologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors. Leukemia. 37(5): 1170-1172. https://doi.org/10.1038/s41375-023-01872-6 PMID: 36973349
  81. Simms KT, Keane A, Nguyen DTN, Caruana M, Hall MT, Lui G, et al. (2023). Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population. Nat Med. 29(12): 3050-3058. https://doi.org/10.1038/s41591-023-02600-4 PMID: 38087115
  82. Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. (2023). Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 11(2): e197-e206. https://doi.org/10.1016/S2214-109X(22)00501-0 PMID: 36528031
  83. Turner MC, Cogliano V, Guyton K, Madia F, Straif K, Ward EM, et al. (2023). Research Recommendations for Selected IARC-Classified Agents: Impact and Lessons Learned. Environ Health Perspect. 131(10): 105001. https://doi.org/10.1289/ehp12547 PMID: 37902675
  84. Van Puyvelde H, Dimou N, Katsikari A, Indave Ruiz BI, Godderis L, Huybrechts I, et al. (2023). The association between dietary intakes of methionine, choline and betaine and breast cancer risk: A systematic review and meta-analysis. Cancer Epidemiol. 83: 102322. https://doi.org/10.1016/j.canep.2023.102322 PMID: 36701983
  85. Zablotska LB, Richardson DB, Golden A, Pasqual E, Smith B, Rage E, et al. (2023). The epidemiology of lung cancer following radiation exposure. Int J Radiat Biol. 99(3): 569-580. https://doi.org/10.1080/09553002.2022.2110321 PMID: 35947399
  86. Baan RA, Straif K (2022). The Monographs Programme of the International Agency for Research on Cancer. A brief history of its Preamble. ALTEX. 39(3): 443-450. https://doi.org/10.14573/altex.2004081 PMID: 34164695
  87. Beard JD, Verdeja MA, Bonsrah DA, Westfall SD, Steege AL, Schubauer-Berigan MK (2022). Crosswalks to Convert US Census Bureau Industry and Occupation Codes, 1980-2018. Epidemiology. 33(2): e8-e9. https://doi.org/10.1097/EDE.0000000000001440 PMID: 34799471
  88. Berney DM, Cree I, Rao V, Moch H, Srigley JR, Tsuzuki T, et al. (2022). An introduction to the WHO 5th edition 2022 classification of testicular tumours. Histopathology. 81(4): 459-466. https://doi.org/10.1111/his.14675 PMID: 35502823
  89. Bouvard V, Nethan ST, Singh D, Warnakulasuriya S, Mehrotra R, Chaturvedi AK, et al. (2022). IARC Perspective on Oral Cancer Prevention. N Engl J Med. 387(21): 1999-2005. https://doi.org/10.1056/NEJMsr2210097 PMID: 36378601
  90. Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, et al. (2022). The IARC Perspective on Cervical Cancer Screening. Obstet Gynecol Surv. 77(3): 154-156. https://doi.org/10.1097/Ogx.0000000000001017
  91. Cierco Jimenez R, Lee T, Rosillo N, Cordova R, Cree IA, Gonzalez A, et al. (2022). Machine learning computational tools to assist the performance of systematic reviews: A mapping review. BMC Med Res Methodol. 22(1): 322. https://doi.org/10.1186/s12874-022-01805-4 PMID: 36522637
  92. Comperat E, Amin MB, Berney DM, Cree I, Menon S, Moch H, et al. (2022). What’s new in WHO fifth edition – urinary tract. Histopathology. 81(4): 439-446. https://doi.org/10.1111/his.14764 PMID: 35942645
  93. Cree IA (2022). From Counting Mitoses to Ki67 Assessment: Technical Pitfalls in the New WHO Classification of Endocrine and Neuroendocrine Tumors. Endocr Pathol. 33(1): 3-5. https://doi.org/10.1007/s12022-021-09701-1 PMID: 35028827
  94. Cree IA (2022). The WHO classification of haematolymphoid tumours: response to Swerdlow et al. Leukemia. 36(11): 2750. https://doi.org/10.1038/s41375-022-01694-y PMID: 36171281
  95. Cree IA (2022). The WHO Classification of Haematolymphoid Tumours. Leukemia. 36(7): 1701-1702. https://doi.org/10.1038/s41375-022-01625-x PMID: 35732830
  96. Cree IA, Lokuhetty D, Tan PH (2022). The World Health Organization Classification of Tumors and External Quality Assurance for Immunohistochemistry and Molecular Pathology. Arch Pathol Lab Med. 146(11): 1303-1307. https://doi.org/10.5858/arpa.2021-0491-RA PMID: 35671156
  97. Del Aguila Mejia J, Armon S, Campbell F, Colling R, Chechlinska M, Kowalewska M, et al. (2022). Understanding the use of evidence in the WHO Classification of Tumours: a protocol for an evidence gap map of the classification of tumours of the lung. BMJ Open. 12(10): e061240. https://doi.org/10.1136/bmjopen-2022-061240 PMID: 36220326
  98. Demers PA, DeMarini DM, Fent KW, Glass DC, Hansen J, Adetona O, et al. (2022). Carcinogenicity of occupational exposure as a firefighter. Lancet Oncol. 23(8): 985-986. https://doi.org/10.1016/S1470-2045(22)00390-4 PMID: 35780778
  99. Goodman S, Chappell G, Guyton KZ, Pogribny IP, Rusyn I (2022). Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: An update of a systematic literature review. Mutat Res Rev Mutat Res. 789: 108408. https://doi.org/10.1016/j.mrrev.2021.108408 PMID: 35690411
  100. Guseva Canu I, Gaillen-Guedy A, Antilla A, Charles S, Fraize-Frontier S, Luce D, et al. (2022). Lung cancer mortality in the European cohort of titanium dioxide workers: a reanalysis of the exposure-response relationship. Occup Environ Med. 79(9): 637-640. https://doi.org/10.1136/oemed-2021-108030 PMID: 35501125
  101. Indave BI, Colling R, Campbell F, Tan PH, Cree IA (2022). Evidence-levels in pathology for informing the WHO classification of tumours. Histopathology. 81(4): 420-425. https://doi.org/10.1111/his.14648 PMID: 36089568
  102. Indave Ruiz BI, Armon S, Watanabe R, Uttley L, White VA, Lazar AJ, et al. (2022). Clonality, Mutation and Kaposi Sarcoma: A Systematic Review. Cancers (Basel). 14(5): 14. https://doi.org/10.3390/cancers14051201 PMID: 35267506
  103. Karagas MR, Wang A, Dorman DC, Hall AL, Pi J, Sergi CM, et al. (2022). Carcinogenicity of cobalt, antimony compounds, and weapons-grade tungsten alloy. Lancet Oncol. 23(5): 577-578. https://doi.org/10.1016/S1470-2045(22)00219-4 PMID: 35397803
  104. Kelly-Reif K, Bertke S, Daniels RD, Richardson DB, Schubauer-Berigan MK (2022). Nonmalignant respiratory disease mortality in male Colorado Plateau uranium miners, 1960-2016. Am J Ind Med. 65(10): 773-782. https://doi.org/10.1002/ajim.23419 PMID: 35941829
  105. Kelly-Reif K, Bertke SJ, Samet J, Sood A, Schubauer-Berigan MK (2022). Health burdens of uranium miners will extend beyond the radiation exposure compensation act deadline. Occup Environ Med. 79(7): 503-504. https://doi.org/10.1136/oemed-2022-108311 PMID: 35501126
  106. Kelly-Reif K, Sandler DP, Shore D, Schubauer-Berigan M, Troester M, Nylander-French L, et al. (2022). Lung and extrathoracic cancer incidence among underground uranium miners exposed to radon progeny in the Pribram region of the Czech Republic: a case-cohort study. Occup Environ Med. 79(2): 102-108. https://doi.org/10.1136/oemed-2021-107392 PMID: 34417337
  107. Kench JG, Amin MB, Berney DM, Comperat EM, Cree IA, Gill AJ, et al. (2022). WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer. Histopathology. 81(4): 447-458. https://doi.org/10.1111/his.14711 PMID: 35758185
  108. Lauby-Secretan B, Mackie A, Wentzensen N (2022). The IARC Perspective on Cervical Cancer Screening. Reply. N Engl J Med. 386(6): 607-608. https://doi.org/10.1056/NEJMc2119177 PMID: 35139285
  109. Lobo J, Ohashi R, Amin MB, Berney DM, Comperat EM, Cree IA, et al. (2022). WHO 2022 landscape of papillary and chromophobe renal cell carcinoma. Histopathology. 81(4): 426-438. https://doi.org/10.1111/his.14700 PMID: 35596618
  110. Luchini C, Pantanowitz L, Adsay V, Asa SL, Antonini P, Girolami I, et al. (2022). Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring. Mod Pathol. 35(6): 712-720. https://doi.org/10.1038/s41379-022-01055-1 PMID: 35249100
  111. Martins B, Normando AGC, Rodrigues-Fernandes CI, Wagner VP, Kowalski LP, Marques SS, et al. (2022). Global frequency and epidemiological profile of electronic cigarette users: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 134(5): 548-561. https://doi.org/10.1016/j.oooo.2022.07.019 PMID: 36182650
  112. Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, et al. (2022). WHO 2022 classification of penile and scrotal cancers: updates and evolution. Histopathology. 82(4): 508-520. https://doi.org/10.1111/his.14824 PMID: 36221864
  113. Michels N, Zouiouich S, Vanderbauwhede B, Vanacker J, Indave Ruiz BI, Huybrechts I (2022). Human microbiome and metabolic health: An overview of systematic reviews. Obes Rev. 23(4): e13409. https://doi.org/10.1111/obr.13409 PMID: 34978141
  114. Middleton DRS, Mmbaga BT, Menya D, Dzamalala C, Nyakunga-Maro G, Finch P, et al. (2022). Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi. Lancet Glob Health. 10(2): e236-e245. https://doi.org/10.1016/S2214-109X(21)00506-4 PMID: 34921758
  115. Moch H, Amin MB, Berney DM, Comperat EM, Gill AJ, Hartmann A, et al. (2022). The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 82(5): 458-468. https://doi.org/10.1016/j.eururo.2022.06.016 PMID: 35853783
  116. Netto GJ, Amin MB, Berney DM, Comperat EM, Gill AJ, Hartmann A, et al. (2022). The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 82(5): 469-482. https://doi.org/10.1016/j.eururo.2022.07.002 PMID: 35965208
  117. Paglioni MP, Khurram SA, Ruiz BII, Lauby-Secretan B, Normando AG, Ribeiro ACP, et al. (2022). Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 134(5): 573-587. https://doi.org/10.1016/j.oooo.2022.07.006 PMID: 36153299
  118. Pfister SM, Reyes-Mugica M, Chan JKC, Hasle H, Lazar AJ, Rossi S, et al. (2022). A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era. Cancer Discov. 12(2): 331-355. https://doi.org/10.1158/2159-8290.CD-21-1094 PMID: 34921008
  119. Pinello K, Baldassarre V, Steiger K, Paciello O, Pires I, Laufer-Amorim R, et al. (2022). Vet-ICD-O-Canine-1, a System for Coding Canine Neoplasms Based on the Human ICD-O-3.2. Cancers (Basel). 14(6). https://doi.org/10.3390/cancers14061529 PMID: 35326681
  120. Reisfeld B, de Conti A, El Ghissassi F, Benbrahim-Tallaa L, Gwinn W, Grosse Y, et al. (2022). kc-hits: a tool to aid in the evaluation and classification of chemical carcinogens. Bioinformatics. 38(10): 2961-2962. https://doi.org/10.1093/bioinformatics/btac189 PMID: 35561175
  121. Richardson DB, Rage E, Demers PA, Do MT, Fenske N, Deffner V, et al. (2022). Lung Cancer and Radon: Pooled Analysis of Uranium Miners Hired in 1960 or Later. Environ Health Perspect. 130(5): 57010. https://doi.org/10.1289/EHP10669 PMID: 35604341
  122. Samet JM, Berrington de Gonzalez A, Lunn RM, Schubauer-Berigan MK (2022). Commentary: Role and communications of cancer hazard determinations. Carcinogenesis. 43(2): 79-81. https://doi.org/10.1093/carcin/bgac001 PMID: 35016221
  123. Thierauf JC, Farahani AA, Indave BI, Bard AZ, White VA, Smith CR, et al. (2022). Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma. Int J Mol Sci. 23(8): 4322. https://doi.org/10.3390/ijms23084322 PMID: 35457138
  124. White VA, Hyrcza MD, Lennerz JK, Thierauf J, Lokuhetty D, Cree IA, et al. (2022). Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities? Mod Pathol. 35(10): 1484-1493. https://doi.org/10.1038/s41379-022-01100-z PMID: 35871081
  125. Yadav K, Cree I, Field A, Vielh P, Mehrotra R (2022). Importance of Cytopathologic Diagnosis in Early Cancer Diagnosis in Resource-Constrained Countries. JCO Glob Oncol. 8: e2100337. https://doi.org/10.1200/GO.21.00337 PMID: 35213215
  View Key Publications Sharing Evidence Synthesis and Classification About Research Publications Related websites Personnel

Từ khóa » Hu Dp Et Al. (indian J Cancer 2021)